Protective Immunity and New Vaccines for Lyme Disease
Clinical Infectious Diseases·
- DOI
- 10.1093/cid/ciz872
- PMID
- 31620776
- PMCID
- PMC7155782
- OpenAlex
- W2980901856
- Study type
- Journal article
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
With Lyme disease cases and geographic range continuing to expand across the Northern Hemisphere, new vaccine strategies—including tick-targeted approaches and deeper understanding of mammalian immune responses to tick-transmitted infection—may offer additional prevention tools beyond traditional host immunization.
Structured evidence summary
Research question
This review examines protective immunity mechanisms and emerging vaccine strategies for Lyme disease, including canonical host-directed vaccines and novel approaches targeting tick-pathogen interactions.
Study design
Narrative review of Lyme disease vaccine development, covering previously identified antigens, novel prevention concepts, and tick immunity research.
Population and setting
The review addresses Lyme disease in the Northern Hemisphere, where it is the most common tick-borne illness with expanding case numbers and geographic spread.
Main findings
The review identifies multiple vaccine design pathways: canonical vaccines using B. burgdorferi proteins, lipid immunogens, and live attenuated mutants targeting host infection; and novel strategies targeting proteins produced during tick transit, tick feeding proteins, and pathogen transmission mechanisms. Understanding the first vaccine's mechanism of action enabled prevention strategies that bypass direct human vaccination.
Public-health relevance
With Lyme disease cases and geographic range continuing to expand across the Northern Hemisphere, new vaccine strategies—including tick-targeted approaches and deeper understanding of mammalian immune responses to tick-transmitted infection—may offer additional prevention tools beyond traditional host immunization.
Important limitations
This summary is limited to the supplied single-article abstract and metadata and requires the original paper for decision-grade interpretation.
GIDS interpretation
This article was identified through disease and topic classifiers for Lyme disease, transmission dynamics, treatment, and vaccination. The review provides context for vaccine development efforts but does not present primary surveillance data or confirm the presence of a live disease signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.